At a maintenance dose of 1.2 to 2.3mg, pricing climbs to $399 to $499 or more a month, which can undo the upfront savings for patients who spend most of treatment at maintenance
For adults who have completed the titration schedule
Plus, FuturHealth charges $129.99 per month for a package that includes access to obesity-trained medical professionals, though discounts are available
Supported by the phase 3 OASIS 4 trial, the 64-week study showed a 13.6% average weight reduction in patients taking Semaglutide versus 2.2% with placebo, along with significant improvements in cardiometabolic risk factors
[1] Whilst Ozempic has demonstrated significant efficacy in glycaemic control and, in adults with type 2 diabetes and established cardiovascular disease, cardiovascular risk reduction, gastrointestinal side effects are amongst the most commonly reported adverse reactions